Summary
- Current Price
- As of today, PASG price is $7.45, down -8.02% on
- Current Price All-Time High
- PASG price is currently -99.03% below its historical high of $764.60 set on
- Market Cap
- PASG current market cap is $24M, down -1.28% year-over-year
- PE Ratio
- PASG PE ratio is unknown
- Revenue
- PASG current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for PASG has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Passage Bio, Inc. |
| Ticker | NASDAQ: PASG |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | passagebio.com |
| Employees | 60 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $7.45 | ||
| Price, 1D Change | -8.02% | |
| $24M | ||
| - | ||
| - | ||
| 2.04 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$14.35 | ||
| EPS, 1Y Change | +33.09% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$14.35 | ||
| EPS Estimate | N/A | -$7.84 |
| EPS Est. Change | N/A | +45.36% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $7.45 | ||
| Price Target | - | $23.00 |
| Price Tgt. Change | - | +208.72% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.83 | -$21.44 | -2,499.30% | |
| -$11.17 | -$14.35 | -28.47% | |
| -$7.84 | N/A | +45.36% | |
| -$5.36 | N/A | +62.64% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -3.50% | ||
| -65.51% | ||
| -1.28% | ||
| -59.85% | ||
| 0.00% | ||
| 0.00% | ||
| +33.09% | ||
| -473.66% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $7.45 | ||
| $8.66 | ||
| SMA 200 vs Price | +16.28% | |
| $11.16 | ||
| SMA 50 vs Price | +49.85% | |
| 2.04 | ||
| $0.98 | ||
| 35.31 | ||
| 79.93% | ||
| 119.28% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$14.35 | ||
| -$728.00K | ||
| - | ||
| -$43.15M | ||
| - | ||
| -$45.52M | ||
| - | ||
| -$42.42M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.28 | ||
| 2.07 | ||
| 2.07 | ||
| - | ||
| - | ||
| -17.33 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.26 | ||
| -0.03 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $18.76M | ||
| $46.30M | ||
| $62.28M | ||
| $47.76M | ||
| $43.53M | ||
| $23.08M | ||
| $24.01M | ||
| $3.57M | ||
| $1.11M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $45.52M | ||
| $42.42M | ||
| $728.00K | ||
| $0.00 | ||
| $728.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$31.51M | ||
| $40.22M | ||
| $23.00K | ||
| $0.00 | ||
| -$31.51M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | → | |
| Chardan Capital | → | |
| Guggenheim | → | |
| Canaccord Genuity | → | |
| Wedbush | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → |
Analyst sentiment
Institutional ownership
Screeners with PASG
FAQ
What is the ticker symbol for Passage Bio, Inc.?
The ticker symbol for Passage Bio, Inc. is NASDAQ:PASG
Does Passage Bio, Inc. pay dividends?
No, Passage Bio, Inc. does not pay dividends
What sector is Passage Bio, Inc. in?
Passage Bio, Inc. is in the Healthcare sector
What industry is Passage Bio, Inc. in?
Passage Bio, Inc. is in the Biotechnology industry
What country is Passage Bio, Inc. based in?
Passage Bio, Inc. is headquartered in United States
When did Passage Bio, Inc. go public?
Passage Bio, Inc. initial public offering (IPO) was on February 28, 2020
Is Passage Bio, Inc. in the S&P 500?
No, Passage Bio, Inc. is not included in the S&P 500 index
Is Passage Bio, Inc. in the NASDAQ 100?
No, Passage Bio, Inc. is not included in the NASDAQ 100 index
Is Passage Bio, Inc. in the Dow Jones?
No, Passage Bio, Inc. is not included in the Dow Jones index
When was Passage Bio, Inc. last earnings report?
Passage Bio, Inc.'s most recent earnings report was on March 3, 2026
When does Passage Bio, Inc. report earnings?
The date for Passage Bio, Inc.'s next earnings report has not been announced yet
Data Sources & References
- PASG Official Website www.passagebio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1787297/000110465926022549/0001104659-26-022549-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1787297/000110465926022549/0001104659-26-022549-index.htm
- PASG Profile on Yahoo Finance finance.yahoo.com/quote/PASG
- PASG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pasg
